Lixiang Education Holding Co., Ltd (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Global Market (“Nasdaq”) on February 6, 2023, confirming that the Company has regained compliance with the Listing Rule 5450(a)(2) (the “Rule”), which requires the Company to have at least 400 public holders for continued listing on the Nasdaq Global Market.
Why 4D Molecular Therapeutics (FDMT) Stock Is Diving
4D Molecular Therapeutics shares are trading lower by 12.7% Wednesday afternoon. The company announced pricing of an upsized underwritten public offering.
